|
May 15
|
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
|
|
May 8
|
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
|
|
May 2
|
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
May 1
|
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
|
|
Apr 24
|
Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026
|
|
Apr 22
|
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
|
|
Apr 18
|
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
|
|
Apr 13
|
Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
|
|
Mar 29
|
Why Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?
|
|
Mar 28
|
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
|
|
Mar 27
|
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
|
|
Mar 27
|
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
|
|
Mar 22
|
Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen strong returns of 271% over the past three years
|
|
Mar 20
|
Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?
|
|
Mar 13
|
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
|
|
Mar 10
|
3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio
|
|
Mar 5
|
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
|
|
Jan 18
|
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
|
|
Jan 15
|
3 Biotech Stocks You Can Buy and Hold for the Next Decade
|
|
Jan 14
|
Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024
|